PMCTPharmaCountry
    ホーム
ARCALIS, Inc. logo
ARCALIS, Inc.

ARCALIS, Inc.

受託製造業者(CMO) · ATC分類(解剖治療化学分類)Flag of JPJapan
1.3K
27
17
3.5(72)

会社概要

  • 正式社名: ARCALIS, Inc.
  • 登録国: Japan
  • 住所: 226-39, Wakashiba,,, Kashiwa Shi
  • 従業員数: 100 - 249
説明:

A CDMO specializing in mRNA medicines and vaccines, founded by Axcelead (Japan's first drug discovery platform) and Arcturus Therapeutics (a US mRNA company). In 2023, ARCALIS opened a GMP mRNA drug substance facility in Japan, and in 2024 achieved the world's first commercial production of a self-amplifying mRNA COVID-19 vaccine, supporting clients from early research through commercial production across rare diseases, oncology, regenerative medicine and genome editing.

事業活動

ATC分類(解剖治療化学分類)

受託製造業者(CMO)
主要製品/サービス

当社の製品・サービス

Sell · Contract & Outsourcing Services
ARCALIS, Inc. sell "Non-GMP mRNA Development & CMC Services"
ARCALIS, Inc.
ARCALIS, Inc.
Flag of JP Japan

ARCALIS, Inc. sell "Non-GMP mRNA Development & CMC Services"

Non-GMP mRNA Development & CMC Services

Service Provider: ARCALIS, Inc., Japan

詳細を見る
Sell · Contract & Outsourcing Services
ARCALIS, Inc. sell "GMP Manufacturing Services for mRNA and LNP"
ARCALIS, Inc.
ARCALIS, Inc.
Flag of JP Japan

ARCALIS, Inc. sell "GMP Manufacturing Services for mRNA and LNP"

GMP Manufacturing Services for mRNA and LNP

Service Provider: ARCALIS, Inc., Japan

詳細を見る

認証

GMP

フィルター:
並べ替え:

    コメントはありません。